More Drug Pusher (Big Pharma) insanity.
 

http://www.newswise.com/articles/new...esearchers-say

"Moreover, the recommendations are based on expert opinion, rather
than solid evidence, the researchers said, which is especially
problematic since the guidelines’ authors disclosed extensive
potential conflicts of interest.

"The guidelines were written by a panel assembled by the National
Heart, Lung and Blood Institute ( NHLBI) and published in Pediatrics,
in November 2011. They also were endorsed by the American Academy of
Pediatrics. The guidelines call for universal screening of all 9 to
11-year-old children with a non-fasting lipid panel, and targeted
screening of 30 to 40 percent of 2 to 8-year-old and 12 to 16-year old
children with two fasting lipid profiles. Previous recommendations
called only for children considered at high risk of elevated levels to
be screened with a simple non-fasting total cholesterol test."

"The authors note that the panel chair and all members who drafted the
lipid screening recommendations disclosed an 'extensive assortment of
financial relationships with companies making lipid lowering drugs and
lipid testing instruments.' Some of those relevant relationships
include paid consultancies or advisory board memberships with
pharmaceuticals that produce cholesterol-lowering drugs such as Merck,
Pfizer, Astra Zeneca, Bristol-Myers Squibb, Roche and Sankyo."

Tar. Feathers. Rail.

--
Dogman

"I have approximate answers and possible beliefs in different degrees of certainty
about different things, but I'm not absolutely sure of anything" - Richard Feynman

More Drug Pusher (Big Pharma) insanity.
 

The author neglected to put the quotation marks around "expert", which would
indicate its fallacious implications.

Dogman wrote:
|
http://www.newswise.com/articles/new...esearchers-say
|
| "Moreover, the recommendations are based on expert opinion, rather
| than solid evidence, the researchers said, which is especially
| problematic since the guidelines' authors disclosed extensive
| potential conflicts of interest.
|
| "The guidelines were written by a panel assembled by the National
| Heart, Lung and Blood Institute ( NHLBI) and published in Pediatrics,
| in November 2011. They also were endorsed by the American Academy of
| Pediatrics. The guidelines call for universal screening of all 9 to
| 11-year-old children with a non-fasting lipid panel, and targeted
| screening of 30 to 40 percent of 2 to 8-year-old and 12 to 16-year old
| children with two fasting lipid profiles. Previous recommendations
| called only for children considered at high risk of elevated levels to
| be screened with a simple non-fasting total cholesterol test."
|
| "The authors note that the panel chair and all members who drafted the
| lipid screening recommendations disclosed an 'extensive assortment of
| financial relationships with companies making lipid lowering drugs and
| lipid testing instruments.' Some of those relevant relationships
| include paid consultancies or advisory board memberships with
| pharmaceuticals that produce cholesterol-lowering drugs such as Merck,
| Pfizer, Astra Zeneca, Bristol-Myers Squibb, Roche and Sankyo."
|
| Tar. Feathers. Rail.